Discontinuation report APTIVUS
| Report ID | 247400 |
| Drug Identification Number | 02273322 |
| Brand name | APTIVUS |
| Common or Proper name | APTIVUS |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | TIPRANAVIR |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1x250 |
| ATC code | J05AE |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-08-31 |
| Actual discontinuation date | |
| Remaining supply date | 2025-08-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | All remaining inventory: June 5, 2026 Expiry Dating. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-01-09 | French | Compare |
| v1 | 2025-01-09 | English | Compare |
Showing 1 to 2 of 2